Eriksson Therese M, Madjid Nather, Elvander-Tottie Elin, Stiedl Oliver, Svenningsson Per, Ogren Sven Ove
Department of Neuroscience, Karolinska Institutet, S-171 77 Stockholm, Sweden.
Neuropharmacology. 2008 Jun;54(7):1041-50. doi: 10.1016/j.neuropharm.2008.02.007. Epub 2008 Apr 3.
Serotonergic (5-HT) neurotransmission plays a role in learning and memory processes, but the physiological role of various receptor subtypes is not well characterised. Among these, 5-HT(1B) receptors are located as autoreceptors on 5-HT axons and heteroreceptors on non-serotonergic terminals. This study examined the role of the 5-HT(1B) receptor in one-trial aversive contextual learning using the passive avoidance (PA) task in NMRI mice. Subcutaneous administration of the 5-HT(1B) receptor agonist anpirtoline (0.1-1.0mg/kg) before PA training impaired retention performance 24h later. Combined administration of anpirtoline with the selective 5-HT(1B) receptor antagonist NAS-181 (0.1-1.0mg/kg) fully blocked the impairments. Administration of NAS-181 alone dose-dependently improved PA retention performance. This facilitatory effect was blocked by subthreshold doses of both the muscarinic antagonist scopolamine (0.03 mg/kg) and the NMDA receptor antagonist MK-801 (0.03 mg/kg). NAS-181 also fully blocked the PA impairments induced by an amnesic dose of scopolamine (0.1mg/kg), when administered prior to, but not after, scopolamine. In addition, NAS-181 attenuated PA impairments induced by MK-801 (0.3mg/kg). These findings indicate that 5-HT(1B) receptors are activated at basal levels of 5-HT transmission. The facilitatory effect of NAS-181 involved alleviation of an inhibitory 5-HT tone mediated via 5-HT(1B) receptors on cholinergic and glutamatergic transmission. This disinhibition is expected to occur in neuronal circuits involved in contextual learning including the hippocampus and interconnected cortico-limbic regions. Blockade of brain 5-HT(1B) heteroreceptors may represent a novel therapeutic strategy for restoration of deficient cholinergic and glutamatergic neurotransmission contributing to memory disorders.
血清素能(5-羟色胺,5-HT)神经传递在学习和记忆过程中发挥作用,但各种受体亚型的生理作用尚未得到充分表征。其中,5-HT(1B)受体作为自身受体位于5-HT轴突上,作为异源受体位于非血清素能终末上。本研究使用NMRI小鼠的被动回避(PA)任务,研究了5-HT(1B)受体在单次厌恶性情境学习中的作用。在PA训练前皮下注射5-HT(1B)受体激动剂安匹托林(0.1 - 1.0mg/kg)会损害24小时后的记忆保持表现。安匹托林与选择性5-HT(1B)受体拮抗剂NAS - 181(0.1 - 1.0mg/kg)联合给药可完全阻断这种损害。单独给予NAS - 181剂量依赖性地改善了PA记忆保持表现。这种促进作用被阈下剂量的毒蕈碱拮抗剂东莨菪碱(0.03mg/kg)和NMDA受体拮抗剂MK - 801(0.03mg/kg)阻断。当在东莨菪碱之前而非之后给药时,NAS - 181也完全阻断了失忆剂量的东莨菪碱(0.1mg/kg)诱导的PA损害。此外,NAS - 181减轻了MK - 801(0.3mg/kg)诱导的PA损害。这些发现表明5-HT(1B)受体在5-HT传递的基础水平上被激活。NAS - 181的促进作用涉及减轻通过5-HT(1B)受体介导的对胆碱能和谷氨酸能传递的抑制性5-HT张力。预计这种去抑制会发生在参与情境学习的神经回路中,包括海马体和相互连接的皮质-边缘区域。阻断脑5-HT(1B)异源受体可能代表一种恢复导致记忆障碍的胆碱能和谷氨酸能神经传递不足的新治疗策略。